Science and serendipity

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 7, Issue 6, 2007, Pages 562-578

  Pepys, Mark B ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Amyloidosis; C reactive protein; Serum amyloid P component

Indexed keywords

C REACTIVE PROTEIN; MEASLES MUMPS RUBELLA VACCINE; PENTRAXIN; SERUM AMYLOID P;

ALZHEIMER DISEASE; AMYLOIDOSIS; AUTISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATIENT CARE; SCINTIGRAPHY; TISSUE INJURY; VACCINATION;

EID: 37148999720     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.7-6-562     Document Type: Conference Paper

References (13)

1. Wilson EO. Consilience: the unity of knowledge. New York: Knopf, 1998.
2. Park R. Voodoo science: the road from foolishness to fraud. Oxford: Oxford University Press, 2001.
3. Feynman RP. Surely you're joking Mr Feynman! Adventures of a curious character. London: Vintage Books, 1985.
4. Tallis R. Longer, healthier, happier? Human needs, human values and science. The Sense about Science Lecture 2007. www.senseaboutscience.org.uk/ index.php/site/project/127
5. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
6. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
7. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
8. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relation of C-reactive protein and coronary heart-disease in the MRFIT nested case control study. Am J Epidemiol 1996;144:537-47.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
10. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
11. Koenig W, Sund M, Fröhlich M et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
12. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 1998;279: 1477-82.
13. Lowe GDO, Pepys MB. C-reactive protein and cardiovascular disease: weighing the evidence. Curr Atheroscler Rep 2006;8:421-8.